Cargando…

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Koizumi, W, Yamaguchi, K, Hosaka, H, Takinishi, Y, Nakayama, N, Hara, T, Muro, K, Baba, H, Sasaki, Y, Nishina, T, Fuse, N, Esaki, T, Takagi, M, Gotoh, M, Sasaki, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264451/ http://dx.doi.org/10.1038/bjc.2014.550

Ejemplares similares

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
por: Koizumi, W, et al.
Publicado: (2013)

MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
por: Wang, H, et al.
Publicado: (2014)

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
por: Koizumi, W, et al.
Publicado: (2003)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer
por: Yamada, Yasuhide, et al.
Publicado: (2019)

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
por: O'Brien, P M, et al.
Publicado: (2008)

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
por: Uchino, H, et al.
Publicado: (2005)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Corrigendum to “Protective effect of aged garlic extract against the oxidative stress induced by cisplatin on blood cells parameters and hepatic antioxidant enzymes in rats” [Toxicol. Rep. 1 (2014) 682–691]
por: Nasr, Ashraf Y.
Publicado: (2017)

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
por: Rocha, C R R, et al.
Publicado: (2015)

Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]
Publicado: (2017)

Corrigendum to “UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells”
por: Wu, Yan, et al.
Publicado: (2020)

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer
por: Yoo, Changhoon, et al.
Publicado: (2016)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
por: Račkauskas, Rokas, et al.
Publicado: (2023)

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2022)

Le programme "TSU-Editor"
por: Hoh, R
Publicado: (1990)

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
por: Kurokawa, Y, et al.
Publicado: (2014)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: Kataoka, Junro, et al.
Publicado: (2017)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

Sam68 is absolutely required for Rev function and HIV-1 production
por: Modem, Suhasini, et al.
Publicado: (2005)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2019)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2021)

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells
por: Wang, Yifei, et al.
Publicado: (2022)

Le TSU: Procédure d'utilisation
por: Frammery, B
Publicado: (1988)

Le TSU: Procédure d'utilisation
por: Frammery, B
Publicado: (1988)

Exosomal-miR-1184 derived from mesenchymal stem cells alleviates cisplatin-associated acute kidney injury
por: Zhang, Jinshi, et al.
Publicado: (2022)

Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer
por: Yamaguchi, Kensei, et al.
Publicado: (2022)

Mode d'emploi du programme TSU archives control pour la manipulation des archives du TSU.
por: Hoh, R
Publicado: (1988)

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma
por: Ikeda, Masafumi, et al.
Publicado: (2014)

Corrigendum to “Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro”
por: Sun, Bishao, et al.
Publicado: (2021)

Pompe turbomoleculaire TSU 330 L/s balzers
por: Versolatto, B
Publicado: (1988)

Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma
por: Chen, Shuwei, et al.
Publicado: (2016)

Hsa-circRNA-G004213 promotes cisplatin sensitivity by regulating miR-513b-5p/PRPF39 in liver cancer
por: Qin, Ling, et al.
Publicado: (2021)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
por: Fukushima, Toshirou, et al.
Publicado: (2014)

Draft Genome Sequence of a New Bacillus cereus Strain tsu1
por: Li, Hui, et al.
Publicado: (2014)

Modulation of cisplatin cytotoxicity by sulphasalazine.
por: Awasthi, S., et al.
Publicado: (1994)

Horizontal transfer and proliferation of Tsu4 in Saccharomyces paradoxus
por: Bergman, Casey M.
Publicado: (2018)

Corrigendum to “Association of Ozone with 5-Fluorouracil and Cisplatin in Regulation of Human Colon Cancer Cell Viability: In Vitro Anti-Inflammatory Properties of Ozone in Colon Cancer Cells Exposed to Lipopolysaccharides”
por: Simonetti, Vincenzo, et al.
Publicado: (2018)

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t69k5nodu5iqp520mr48jretqu